Bone Metabolism Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Description

GlobalData's Medical Devices sector report, "Bone Metabolism Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Bone Metabolism Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bone Metabolism Assays includes laboratory tests that examine the mineral composition of the bones and the parameters of bone formation and resorption.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Bone Metabolism Assays under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Bone Metabolism Assays and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Bone Metabolism Assays under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1758EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Bone Metabolism Assays Overview

3 Products under Development

3.1 Bone Metabolism Assays - Pipeline Products by Stage of Development
3.2 Bone Metabolism Assays - Pipeline Products by Segment
3.3 Bone Metabolism Assays - Pipeline Products by Territory
3.4 Bone Metabolism Assays - Pipeline Products by Regulatory Path
3.5 Bone Metabolism Assays - Pipeline Products by Estimated Approval Date

4 Bone Metabolism Assays - Pipeline Products under Development by Companies

4.1 Bone Metabolism Assays Companies - Pipeline Products by Stage of Development
4.2 Bone Metabolism Assays - Pipeline Products by Stage of Development

5 Bone Metabolism Assays Companies and Product Overview

5.1 AMS Diagnostics LLC Company Overview
- 5.1.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Axis-Shield Diagnostics Ltd Company Overview
- 5.2.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Carolina Liquid Chemistries Corp Company Overview
- 5.3.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 DiaSorin SpA Company Overview
- 5.4.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.5 Guangzhou Wondfo Biotech Co Ltd Company Overview
- 5.5.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Roche Diagnostics Corp Company Overview
- 5.6.1 Roche Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
- 5.7.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Siemens Healthcare Diagnostics Inc Company Overview
- 5.8.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Tosoh Bioscience Inc Company Overview
- 5.9.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Bone Metabolism Assays- Recent Developments

6.1 May 14, 2024: NIH-Funded Study Shows BDI's Bone Density Test Using Existing CT Images Predicts Fractures
6.2 Apr 22, 2024: Shenzhen New Industries Biomedical Engineering Receives FDA 510(k) Clearance for MAGLUMI 25-OH Vitamin D Assay
6.3 Apr 04, 2024: Roche Diagnostics Receives Additional 510(K) Clearance for Elecsys PTH Assay
6.4 Mar 20, 2024: Abingdon Health : Launch of OEM self-tests in Boots
6.5 Mar 11, 2024: Beckman Coulter Receives FDA 510(k) Clearance for Access Intact PTH

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer